Lv1
50 积分 2024-04-10 加入
From concept to clinic: Cutting-Edge advances steering the next wave of antibody–drug conjugates innovation
3个月前
已完结
Immunotherapy for advanced-stage squamous cell lung cancer: the state of the art and outstanding questions
3个月前
已完结
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy in advanced squamous non-small-cell lung cancer (HARMONi-6): interim overall survival analysis of a randomised, double-blind, phase 3 trial in China
3个月前
已完结
Treatment of NSCLC after chemoimmunotherapy — are we making headway?
3个月前
已完结
Alirocumab plus cemiplimab in advanced immuno-refractory metastatic non-small cell lung cancer: an ongoing multi-center phase II study
3个月前
已完结
The next generation of immunotherapies for lung cancers
3个月前
已完结
Ziftomenib in relapsed or refractory acute myeloid leukaemia (KOMET-001): a multicentre, open-label, multi-cohort, phase 1 trial
5个月前
已完结
A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: a molecular epidemiological study
5个月前
已完结
Efficacy and Safety of Spleen Tyrosine Kinase and VEGFR-2 Dual-Target Kinase Inhibitor (OT202) in Dry Eye
5个月前
已完结
The JRS guideline for the management of pneumonia in adults 2024
5个月前
已完结
皖公网安备34019202002308
